Function Health Acquires Ezra, Unveils Affordable Full-Body Scan
Function Health has announced the acquisition of Ezra, a company specializing in full-body MRI scanning, and introduced a new, more affordable scanning option.
With a newly launched full-body scan priced at $499, Function Health is expanding its subscription service. This annual membership allows users to undergo over 160 blood tests, tracking their health metrics comprehensively over time. By incorporating Ezra's technology, Function Health aims to enhance the accuracy and scope of its health assessments.
"The integration is logical," stated Jonathan Swerdlin, Function's CEO and co-founder. "Where laboratory tests have limitations, MRI scans provide insights, and vice versa."
While the financial arrangements of the acquisition remain undisclosed, this move marks a significant shift from Ezra's previous offer, which was priced at $1,495 for a 30-minute session.
Established in 2018, Ezra provides various MRI scanning services, partnering with numerous existing imaging centers across the United States.
The popularity of full-body MRI scans has been growing, fueled by endorsements from celebrities. However, the medical community holds differing opinions, citing concerns about the costs and potential for undue anxiety among patients.
Industry Dynamics
Ezra's primary market rival is another firm focusing on full-body scanning. Earlier this year, the competitor secured substantial funding and broadened its services with a new blood test.
Function, aiming to attract significant new investment, has accumulated $53 million in funding, surpassing Ezra's $44 million. The company's ambition is to raise an additional $200 million, with its valuation nearing $2 billion.
Emi Gal, Ezra's founder and CEO, has been in contact with Swerdlin for some time, and what began as a potential partnership evolved into the acquisition.
Gal expressed his excitement over the acquisition, noting the merger's potential for transformative impact.
The reduced scan time, achieved through AI technology approved by the FDA, coupled with Function's financial resources, enables the lower price point for the scan.
The shorter and cost-effective scan is accessible to Function's members, although the company has not disclosed the exact number of its subscribers.
Dr. Mark Hyman, co-founder of Function, views the acquisition as a logical advancement in making comprehensive medical imaging available to a broader audience.
"Access to detailed imaging has moved beyond the affluent, providing life-saving insights," Hyman remarked.




Leave a Reply